By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Pivotal Therapeutics Inc.  

3701 FAU Blvd, Building 3, Suite 210

Boca Raton  Florida   33431  U.S.A.
Phone: 561-288-5231 Fax: n/a



Company News
Pivotal Therapeutics Inc. Release: VASCAZEN POMEGA Phase 2a Trial Protocol Cleared Clinical Evaluation By French FDA 12/17/2014 8:49:35 AM
Pivotal Therapeutics Inc. Announces Third Quarter Accomplishments And Financial Results 12/1/2014 9:14:05 AM
Pivotal Therapeutics Inc. Announces Senior Management Change 11/17/2014 11:24:30 AM
Pivotal Therapeutics Inc. Receives Notification Of Allowance For U.S. Patent Related To Combination VASCAZEN® And Cholesterol Absorption Inhibitor 10/8/2014 11:28:44 AM
Pivotal Therapeutics Inc. Announces Notification Of Patent Allowance For U.S. Application 13/584,480 Related To Combination Product Of VASCAZEN® And Statin Therapy 10/7/2014 8:56:07 AM
Pivotal Therapeutics Inc. Announces Payment Of Interest On Outstanding Convertible Notes 10/6/2014 8:58:02 AM
Pivotal Therapeutics Inc. Grants Incentive Stock Options 9/16/2014 9:09:30 AM
Pivotal Therapeutics Inc. Announces Publication Of A Clinical Trial Showing Beneficial Effects Of VASCAZEN® In The Correction Of Omega-3 Deficiency In Cardiovascular Patients 9/10/2014 8:02:02 AM
Pivotal Therapeutics Inc. Appoints Accomplished Healthcare And Investment Industry Veteran, Prakash Gowd, As Chief Financial Officer 9/8/2014 10:31:58 AM
Pivotal Therapeutics Inc. Release: Unique Vasoprotective And Antihypertensive Effects Of VASCAZEN®'s Formulation Presented At European Society of Cardiology Congress 2014 9/5/2014 12:47:29 PM